181 related articles for article (PubMed ID: 37160317)
1. Melanoma in a patient with DNMT3A overgrowth syndrome.
Chen DY; Sutton LA; Ramakrishnan SM; Duncavage EJ; Heath SE; Compton LA; Miller CA; Ley TJ
Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 37160317
[TBL] [Abstract][Full Text] [Related]
2. Dnmt3a deficiency in the skin causes focal, canonical DNA hypomethylation and a cellular proliferation phenotype.
Chen DY; Ferguson IM; Braun KA; Sutton LA; Helton NM; Ramakrishnan SM; Smith AM; Miller CA; Ley TJ
Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33846253
[TBL] [Abstract][Full Text] [Related]
3. Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome.
Tovy A; Rosas C; Gaikwad AS; Medrano G; Zhang L; Reyes JM; Huang YH; Arakawa T; Kurtz K; Conneely SE; Guzman AG; Aguilar R; Gao A; Chen CW; Kim JJ; Carter MT; Lasa-Aranzasti A; Valenzuela I; Van Maldergem L; Brunetti L; Hicks MJ; Marcogliese AN; Goodell MA; Rau RE
Haematologica; 2022 Apr; 107(4):887-898. PubMed ID: 34092059
[TBL] [Abstract][Full Text] [Related]
4. Skeletal abnormalities in mice with Dnmt3a missense mutations.
Bell-Hensley A; Beard DC; Feeney K; Zheng H; Jiang Y; Zhang X; Liu J; Gabel H; McAlinden A
Bone; 2024 Jun; 183():117085. PubMed ID: 38522809
[TBL] [Abstract][Full Text] [Related]
5. The spectrum of DNMT3A variants in Tatton-Brown-Rahman syndrome overlaps with that in hematologic malignancies.
Shen W; Heeley JM; Carlston CM; Acuna-Hidalgo R; Nillesen WM; Dent KM; Douglas GV; Levine KL; Bayrak-Toydemir P; Marcelis CL; Shinawi M; Carey JC
Am J Med Genet A; 2017 Nov; 173(11):3022-3028. PubMed ID: 28941052
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukaemia in a case with Tatton-Brown-Rahman syndrome: the peculiar
Hollink IHIM; van den Ouweland AMW; Beverloo HB; Arentsen-Peters STCJM; Zwaan CM; Wagner A
J Med Genet; 2017 Dec; 54(12):805-808. PubMed ID: 28432085
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia-associated DNMT3A p.Arg882His mutation in a patient with Tatton-Brown-Rahman overgrowth syndrome as a constitutional mutation.
Kosaki R; Terashima H; Kubota M; Kosaki K
Am J Med Genet A; 2017 Jan; 173(1):250-253. PubMed ID: 27991732
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability.
Tatton-Brown K; Seal S; Ruark E; Harmer J; Ramsay E; Del Vecchio Duarte S; Zachariou A; Hanks S; O'Brien E; Aksglaede L; Baralle D; Dabir T; Gener B; Goudie D; Homfray T; Kumar A; Pilz DT; Selicorni A; Temple IK; Van Maldergem L; Yachelevich N; ; van Montfort R; Rahman N
Nat Genet; 2014 Apr; 46(4):385-8. PubMed ID: 24614070
[TBL] [Abstract][Full Text] [Related]
9. Gain-of-function mutations in DNMT3A in patients with paraganglioma.
Remacha L; Currás-Freixes M; Torres-Ruiz R; Schiavi F; Torres-Pérez R; Calsina B; Letón R; Comino-Méndez I; Roldán-Romero JM; Montero-Conde C; Santos M; Pérez LI; Pita G; Alonso MR; Honrado E; Pedrinaci S; Crespo-Facorro B; Percesepe A; Falcioni M; Rodríguez-Perales S; Korpershoek E; Ramón-Maiques S; Opocher G; Rodríguez-Antona C; Robledo M; Cascón A
Genet Med; 2018 Dec; 20(12):1644-1651. PubMed ID: 29740169
[TBL] [Abstract][Full Text] [Related]
10.
Tlemsani C; Luscan A; Leulliot N; Bieth E; Afenjar A; Baujat G; Doco-Fenzy M; Goldenberg A; Lacombe D; Lambert L; Odent S; Pasche J; Sigaudy S; Buffet A; Violle-Poirsier C; Briand-Suleau A; Laurendeau I; Chin M; Saugier-Veber P; Vidaud D; Cormier-Daire V; Vidaud M; Pasmant E; Burglen L
J Med Genet; 2016 Nov; 53(11):743-751. PubMed ID: 27317772
[TBL] [Abstract][Full Text] [Related]
11. AML-Associated Mutations in DNA Methyltransferase DNMT3A.
Khrabrova DA; Yakubovskaya MG; Gromova ES
Biochemistry (Mosc); 2021 Mar; 86(3):307-318. PubMed ID: 33838631
[TBL] [Abstract][Full Text] [Related]
12. Germline DNMT3A mutation in familial acute myeloid leukaemia.
DiNardo CD; Beird HC; Estecio M; Hardikar S; Takahashi K; Bannon SA; Borthakur G; Jabbour E; Gumbs C; Khoury JD; Routbort M; Gong T; Kondo K; Kantarjian H; Garcia-Manero G; Chen T; Futreal PA
Epigenetics; 2021 May; 16(5):567-576. PubMed ID: 32856987
[TBL] [Abstract][Full Text] [Related]
13. Co-occurrence of a maternally inherited
Polonis K; Blackburn PR; Urrutia RA; Lomberk GA; Kruisselbrink T; Cousin MA; Boczek NJ; Hoppman NL; Babovic-Vuksanovic D; Klee EW; Pichurin PN
Cold Spring Harb Mol Case Stud; 2018 Aug; 4(4):. PubMed ID: 29802153
[TBL] [Abstract][Full Text] [Related]
14. Impact of DNA methyltransferases on the epigenetic regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in malignant melanoma.
Venza M; Visalli M; Catalano T; Fortunato C; Oteri R; Teti D; Venza I
Biochem Biophys Res Commun; 2013 Nov; 441(4):743-50. PubMed ID: 24211571
[TBL] [Abstract][Full Text] [Related]
15. Further delineation of neuropsychiatric findings in Tatton-Brown-Rahman syndrome due to disease-causing variants in DNMT3A: seven new patients.
Tenorio J; Alarcón P; Arias P; Dapía I; García-Miñaur S; Palomares Bralo M; Campistol J; Climent S; Valenzuela I; Ramos S; Monseny AM; Grondona FL; Botet J; Serrano M; Solís M; Santos-Simarro F; Álvarez S; Teixidó-Tura G; Fernández Jaén A; Gordo G; Bardón Rivera MB; Nevado J; Hernández A; Cigudosa JC; Ruiz-Pérez VL; Tizzano EF; ; Lapunzina P
Eur J Hum Genet; 2020 Apr; 28(4):469-479. PubMed ID: 31685998
[TBL] [Abstract][Full Text] [Related]
16. Novel DNMT3A germline mutations are associated with inherited Tatton-Brown-Rahman syndrome.
Xin B; Cruz Marino T; Szekely J; Leblanc J; Cechner K; Sency V; Wensel C; Barabas M; Therriault V; Wang H
Clin Genet; 2017 Apr; 91(4):623-628. PubMed ID: 27701732
[TBL] [Abstract][Full Text] [Related]
17. The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape.
Weinberg DN; Papillon-Cavanagh S; Chen H; Yue Y; Chen X; Rajagopalan KN; Horth C; McGuire JT; Xu X; Nikbakht H; Lemiesz AE; Marchione DM; Marunde MR; Meiners MJ; Cheek MA; Keogh MC; Bareke E; Djedid A; Harutyunyan AS; Jabado N; Garcia BA; Li H; Allis CD; Majewski J; Lu C
Nature; 2019 Sep; 573(7773):281-286. PubMed ID: 31485078
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia.
Gupta S; Erickson LA; Lohse CM; Shen W; Pitel BA; Knight SM; Halling KC; Herrera-Hernandez L; Boorjian SA; Thompson RH; Leibovich BC; Jimenez RE; Cheville JC
JAMA Netw Open; 2021 Nov; 4(11):e2132615. PubMed ID: 34767027
[TBL] [Abstract][Full Text] [Related]
19. Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation.
Mayle A; Yang L; Rodriguez B; Zhou T; Chang E; Curry CV; Challen GA; Li W; Wheeler D; Rebel VI; Goodell MA
Blood; 2015 Jan; 125(4):629-38. PubMed ID: 25416277
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of DNMT3A alterations in Middle Eastern papillary thyroid carcinoma.
Siraj AK; Pratheeshkumar P; Parvathareddy SK; Bu R; Masoodi T; Iqbal K; Al-Rasheed M; Al-Dayel F; Al-Sobhi SS; Alzahrani AS; Al-Dawish M; Al-Kuraya KS
Eur J Cancer; 2019 Aug; 117():133-144. PubMed ID: 31280122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
